These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20436437)

  • 1. [Duloxetine in the treatment of chronic migraine].
    Artemenko AR; Kurenkov AL; Nikitin SS; Filatova EG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):49-54. PubMed ID: 20436437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine prophylaxis for episodic migraine in persons without depression: a prospective study.
    Young WB; Bradley KC; Anjum MW; Gebeline-Myers C
    Headache; 2013 Oct; 53(9):1430-7. PubMed ID: 24032526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of duloxetine in the treatment of chronic daily headache].
    Artemenko AR; Kurenkov AL; Filatova EG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(8):24-8. PubMed ID: 18379468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blink reflex in "chronic migraine".
    De Marinis M; Pujia A; Colaizzo E; Accornero N
    Clin Neurophysiol; 2007 Feb; 118(2):457-63. PubMed ID: 17141567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain reflexes in the clinical assessment of migraine syndromes.
    Sandrini G; Martignoni E; Micieli G; Alfonsi E; Sances G; Nappi G
    Funct Neurol; 1986; 1(4):423-9. PubMed ID: 3609872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic back pain with antidepressant cymbalta: an experimental study].
    Voznesenskaia TG; Leonova AR; Kaverina IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(7):20-4. PubMed ID: 18379477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-blind, placebo run-in study of duloxetine for activity-limiting osteoarthritis pain.
    Sullivan MD; Bentley S; Fan MY; Gardner G
    J Pain; 2009 Feb; 10(2):208-13. PubMed ID: 18976962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J
    Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder.
    Curone M; Tullo V; Savino M; Proietti-Cecchini A; Bussone G; D'Amico D
    Neurol Sci; 2013 May; 34 Suppl 1():S175-7. PubMed ID: 23695074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of depression-symptom improvement during treatment with duloxetine.
    Hirschfeld RM; Mallinckrodt C; Lee TC; Detke MJ
    Depress Anxiety; 2005; 21(4):170-7. PubMed ID: 16035056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical referral of head pain in migraineurs: effects on the nociceptive blink reflex.
    Watson DH; Drummond PD
    Headache; 2014 Jun; 54(6):1035-45. PubMed ID: 24666216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal habituation of 'nociceptive' blink reflex in migraine--evidence for increased excitability of trigeminal nociception.
    Katsarava Z; Giffin N; Diener HC; Kaube H
    Cephalalgia; 2003 Oct; 23(8):814-9. PubMed ID: 14510928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cymbalta in the treatment of chronic pain syndromes].
    Odinak MM; Kashin AV; Ememlin AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):32-4. PubMed ID: 19365388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients.
    Sandrini G; Rossi P; Milanov I; Serrao M; Cecchini AP; Nappi G
    Cephalalgia; 2006 Jul; 26(7):782-9. PubMed ID: 16776692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder.
    Meighen KG
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):121-7. PubMed ID: 17343560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.
    Skljarevski V; Zhang S; Chappell AS; Walker DJ; Murray I; Backonja M
    Pain Med; 2010 May; 11(5):648-57. PubMed ID: 20546509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of depression relapse: re-initiation of duloxetine treatment or dose increase.
    Fava M; Detke MJ; Balestrieri M; Wang F; Raskin J; Perahia D
    J Psychiatr Res; 2006 Jun; 40(4):328-36. PubMed ID: 16678205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey.
    Waldschmitt C; Vogel F; Pfuhlmann B; Hiemke C
    Pharmacopsychiatry; 2009 Sep; 42(5):189-93. PubMed ID: 19724981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.